Search Results - "Godse, Neelima"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration

    A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration by Singh, Ramandeep, Chauhan, Rohan, Saxena, Ashish, Shah, Anup, Mondal, Laxshmi, Bakhle, Dhananjay, Shah, Chirag, Shah, Arpit, Deoghare, Shashank, Krishnan, Neelakant, Godse, Neelima

    Published in Indian journal of ophthalmology (01-08-2022)
    “…Purpose: The present study compares the efficacy, safety, and immunogenicity of Lupin's biosimilar ranibizumab with that of Lucentis® in patients with…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects

    An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects by Shennak, Mustafa, Al-Jaouni, Rana, Kshirasagar, Santhosh, Kasibhatta, Ravi Sekhar, Godse, Neelima, Al-Ghazawi, Ahmad, Vittala, Praveen, Bakhle, Dhananjay

    “…Background and Objectives YLB113 is being developed as a biosimilar of the antitumor necrosis factor-alpha antagonist etanercept, which is approved for the…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: